Kedudukan dalam Saham
#37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Harga Saham
$0.00060315
Disegerakkan terakhir: 2024-09-27
Perubahan (1 hari)
19.64%
Perubahan (1 tahun)
0.00%
Perdagangan Amniotics AB (publ) (AMNI)
Harga AMNI dengan permodalan pasaran b
Modal pasaran bagi Amniotics AB (publ)(AMNI)
Modal Pasaran: $1.65M
Sehingga August 2026, Amniotics AB (publ) mempunyai modal pasaran sebanyak $1.65M. Ini menjadikan Amniotics AB (publ) syarikat ke-37511th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Amniotics AB (publ) dari 2021 hingga 2026
AMNI berbanding dengan 5 teratas yang paling popular stocks
| Harga AMNI |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+330,719,226.46%
|
|
|
|
|
$4.490T
|
+272,371,960.14%
|
|
|
|
|
$4.162T
|
+252,498,403.81%
|
|
|
|
|
$3.676T
|
+223,012,921.38%
|
|
|
|
|
$2.833T
|
+171,856,957.95%
|
